Sequenom to Raise $51.6M in Private Placement

The firm will use the funds for its R&D efforts and for commercialization of diagnostic tests, particularly its non-invasive test for Down syndrome.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories